Oxford Global Conferences – 7th Annual Biomarkers Congress

Over 250 Industry Delegates

Over 55 presentations/roundtables/panel discussions

4 Interactive Streams:

Biomarker Discovery & Validation Strategies and Regulation

Companion Diagnostics and Personalized Medicine

Safety and Biomarkers In Clinical Development

Enabling Technologies to Maximise Biomarker Identification

Co-located 1st Annual CNS Biomarkers Congress

14 pre-scheduled one to one business meetings

The pharmaceutical industry is facing high clinical development costs and declining drug discovery success rates. To stay competitive companies are re-evaluating their drug development process to reduce attrition rates. Biomarkers promise to transform drug discovery, clinical development and diagnostics in the R&D process as effective use of biomarkers at each stage of R&D can improve decision-making, increase clinical trial success rates and productivity.

The 7th Annual Biomarkers Congress 2012 presented by Oxford Global Conferences provides a first class educational and networking opportunity for over 250 attendees to gain knowledge and insights into the Biomarkers marketplace.

Do not miss out on the opportunity to learn how you can streamline your R&D process and identify potential cost savings through successful biomarker discovery, validation and clinical development.

Our CNS Biomarkers Congress 2012 which will be co-located with the 7th Annual Biomarkers Congress on the 21- 22 February will provide the opportunity for two days worth of deep analysis and insight into this growing CNS Biomarkers market.

These prestigious events provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, analysis of current technologies and their applications, network with their peers and address key industry concerns through a series of cutting edge conference presentations and interactive exhibition room in a professional yet relaxed environment.